Vanesa Bernal-Monterde (V Bernal Monterde)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 22

Top Topics

Hepatitis C Virus

Cardiovascular Risk Factors

Top Venues

Journal of clinical medicine

Alimentary pharmacology & therapeutics

Pathogens (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Andrea Pascual-Oliver, Diego Casas Deza, Carmen Yagüe-Caballero, Jose Miguel Arbones-Mainar, Vanesa Bernal-Monterde
Lipid Profile and Cardiovascular Risk Modification after Hepatitis C Virus Eradication. Pathogens (Basel, Switzerland) 13 (4) (2024)
Marta Lopez-Yus, Carlos Hörndler, Sofia Borlan, Vanesa Bernal-Monterde, Jose Miguel Arbones-Mainar
Unraveling Adipose Tissue Dysfunction: Molecular Mechanisms, Novel Biomarkers, and Therapeutic Targets for Liver Fat Deposition. Cells 13 (5) (2024)
Andrea Pascual-Oliver, Diego Casas Deza, Carmen Yagüe-Caballero, Jose Miguel Arbones-Mainar, Vanesa Bernal-Monterde
Lipid Profile and Cardiovascular Risk Modification after Hepatitis C Virus Eradication. Pathogens (Basel, Switzerland) 13 (4) (2024)
Juan-Carlos Ruiz-Cobo, Jordi Llaneras, Xavier Forns, Adolfo Gallego Moya, Isabel Conde Amiel, Ana Arencibía, Moises Diago, Javier García-Samaniego, Jose Castellote, Susana Llerena, Elisa Rodríguez-Seguel, Beatriz Mateos, Manuel Rodríguez, Jose Miguel Rosales Zabal, Inmaculada Fernández, Jose Luis Calleja, Rosa María Morillas, Silvia Montoliu, Raúl Jesús Andrade, Ester Badia Aranda, Manuel Hernández Guerra, Carlota Jimeno Maté, Jesús M González-Santiago, Beatriz de Cuenca, Vanesa Bernal-Monterde, Manuel Delgado, Juan Turnes Vázquez, Sabela Lens, Maria Buti Ferret
Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir. Alimentary pharmacology & therapeutics 60 (2) (2024)
Andrea Pascual-Oliver, Diego Casas Deza, Carmen Yagüe-Caballero, Jose Miguel Arbones-Mainar, Vanesa Bernal-Monterde
Lipid Profile and Cardiovascular Risk Modification after Hepatitis C Virus Eradication. Pathogens (Basel, Switzerland) 13 (4) (2024)
Juan-Carlos Ruiz-Cobo, Jordi Llaneras, Xavier Forns, Adolfo Gallego Moya, Isabel Conde Amiel, Ana Arencibía, Moises Diago, Javier García-Samaniego, Jose Castellote, Susana Llerena, Elisa Rodríguez-Seguel, Beatriz Mateos, Manuel Rodríguez, Jose Miguel Rosales Zabal, Inmaculada Fernández, Jose Luis Calleja, Rosa María Morillas, Silvia Montoliu, Raúl Jesús Andrade, Ester Badia Aranda, Manuel Hernández Guerra, Carlota Jimeno Maté, Jesús M González-Santiago, Beatriz de Cuenca, Vanesa Bernal-Monterde, Manuel Delgado, Juan Turnes Vázquez, Sabela Lens, Maria Buti Ferret
Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir. Alimentary pharmacology & therapeutics 60 (2) (2024)
Marta Lopez-Yus, Carlos Hörndler, Sofia Borlan, Vanesa Bernal-Monterde, Jose Miguel Arbones-Mainar
Unraveling Adipose Tissue Dysfunction: Molecular Mechanisms, Novel Biomarkers, and Therapeutic Targets for Liver Fat Deposition. Cells 13 (5) (2024)
Marta Lopez-Yus, Carlos Hörndler, Sofia Borlan, Vanesa Bernal-Monterde, Jose Miguel Arbones-Mainar
Unraveling Adipose Tissue Dysfunction: Molecular Mechanisms, Novel Biomarkers, and Therapeutic Targets for Liver Fat Deposition. Cells 13 (5) (2024)
Juan-Carlos Ruiz-Cobo, Jordi Llaneras, Xavier Forns, Adolfo Gallego Moya, Isabel Conde Amiel, Ana Arencibía, Moises Diago, Javier García-Samaniego, Jose Castellote, Susana Llerena, Elisa Rodríguez-Seguel, Beatriz Mateos, Manuel Rodríguez, Jose Miguel Rosales Zabal, Inmaculada Fernández, Jose Luis Calleja, Rosa María Morillas, Silvia Montoliu, Raúl Jesús Andrade, Ester Badia Aranda, Manuel Hernández Guerra, Carlota Jimeno Maté, Jesús M González-Santiago, Beatriz de Cuenca, Vanesa Bernal-Monterde, Manuel Delgado, Juan Turnes Vázquez, Sabela Lens, Maria Buti Ferret
Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir. Alimentary pharmacology & therapeutics 60 (2) (2024)
Juan-Carlos Ruiz-Cobo, Jordi Llaneras, Xavier Forns, Adolfo Gallego Moya, Isabel Conde Amiel, Ana Arencibía, Moises Diago, Javier García-Samaniego, Jose Castellote, Susana Llerena, Elisa Rodríguez-Seguel, Beatriz Mateos, Manuel Rodríguez, Jose Miguel Rosales Zabal, Inmaculada Fernández, Jose Luis Calleja, Rosa María Morillas, Silvia Montoliu, Raúl Jesús Andrade, Ester Badia Aranda, Manuel Hernández Guerra, Carlota Jimeno Maté, Jesús M González-Santiago, Beatriz de Cuenca, Vanesa Bernal-Monterde, Manuel Delgado, Juan Turnes Vázquez, Sabela Lens, Maria Buti Ferret
Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir. Alimentary pharmacology & therapeutics (2024)
Diego Casas Deza, Vanesa Bernal-Monterde, Elena Betoré-Glaria, Ana Belén Julián-Gomara, Carmen Yagüe-Caballero, Alejandro Sanz-París, Eva María Fernández-Bonilla, Javier Fuentes-Olmo, Jose Miguel Arbones-Mainar
Liver Disease Undernutrition Screening Tool Questionnaire Predicts Decompensation and Mortality in Cirrhotic Outpatients with Portal Hypertension. Nutrients 15 (17) (2023)
Diego Casas Deza, Ana Martínez-Sapiña, Silvia Espina, Beatriz Garcia-Rodriguez, Eva M Fernandez-Bonilla, Alejandro Sanz-París, Yolanda Gonzalez-Irazabal, Vanesa Bernal-Monterde, Jose Miguel Arbones-Mainar
Evaluation of Cardiovascular Risk Factors after Hepatitis C Virus Eradication with Direct-Acting Antivirals in a Cohort of Treatment-Naïve Patients without History of Cardiovascular Disease. Journal of clinical medicine 11 (14) (2022)
Silvia Espina, Alejandro Sanz-París, Vanesa Bernal-Monterde, Diego Casas Deza, Jose Miguel Arbones-Mainar
Role of Branched-Chain Amino Acids and Their Derivative β-Hydroxy-β-Methylbutyrate in Liver Cirrhosis. Journal of clinical medicine 11 (24) (2022)
Silvia Espina, Alejandro Sanz-París, Vanesa Bernal-Monterde, Diego Casas Deza, Jose Miguel Arbones-Mainar
Role of Branched-Chain Amino Acids and Their Derivative β-Hydroxy-β-Methylbutyrate in Liver Cirrhosis. Journal of clinical medicine 11 (24) (2022)
Silvia Espina, Alejandro Sanz-París, Vanesa Bernal-Monterde, Diego Casas Deza, Jose Miguel Arbones-Mainar
Role of Branched-Chain Amino Acids and Their Derivative β-Hydroxy-β-Methylbutyrate in Liver Cirrhosis. Journal of clinical medicine 11 (24) (2022)
Silvia Espina, Alejandro Sanz-París, Vanesa Bernal-Monterde, Diego Casas Deza, Jose Miguel Arbones-Mainar
Role of Branched-Chain Amino Acids and Their Derivative β-Hydroxy-β-Methylbutyrate in Liver Cirrhosis. Journal of clinical medicine 11 (24) (2022)
Marta López-Yus, Silvia Lorente-Cebrián, Raquel Del Moral-Bergos, Carlos Hörndler, Maria Pilar Garcia-Sobreviela, Carmen Casamayor, Alejandro Sanz-París, Vanesa Bernal-Monterde, Jose Miguel Arbones-Mainar
Identification of novel targets in adipose tissue involved in non-alcoholic fatty liver disease progression. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 36 (8) (2022)
Silvia Espina, Alejandro Sanz-París, Yolanda Gonzalez-Irazabal, Patricia Pérez-Matute, Fernando Andrade, Beatriz Garcia-Rodriguez, Christian Carpéné, Alexia Zakaroff, Vanesa Bernal-Monterde, Javier Fuentes-Olmo, Jose Miguel Arbones-Mainar
Randomized Clinical Trial: Effects of β-Hydroxy-β-Methylbutyrate (HMB)-Enriched vs. HMB-Free Oral Nutritional Supplementation in Malnourished Cirrhotic Patients. Nutrients 14 (11) (2022)
Lamuela L J Calvo, P García Cámara, M Llorente Barrio, O Sierra Gabarda, R Monzón Baez, J M Arbonés Mainar, J Alcedo González, Vanesa Bernal-Monterde
Successful deprescribing of proton pump inhibitors with a patient-centered process: the DESPIBP Project. European journal of clinical pharmacology 77 (12) (2021)
Pablo Cañamares-Orbis, Vanesa Bernal-Monterde, Olivia Sierra-Gabarda, Diego Casas Deza, Guillermo Garcia-Rayado, Luis Cortes, Alberto Lue
Impact of Liver and Pancreas Diseases on Nutritional Status. Nutrients 13 (5) (2021)
Silvia Espina, Yolanda Gonzalez-Irazabal, Alejandro Sanz-París, Marta Lopez-Yus, Maria Pilar Garcia-Sobreviela, Raquel Del Moral-Bergos, Beatriz Garcia-Rodriguez, Javier Fuentes-Olmo, Vanesa Bernal-Monterde, Jose Miguel Arbones-Mainar
Amino Acid Profile in Malnourished Patients with Liver Cirrhosis and Its Modification with Oral Nutritional Supplements: Implications on Minimal Hepatic Encephalopathy. Nutrients 13 (11) (2021)
Vanesa Bernal-Monterde, Diego Casas Deza, Laura Letona-Giménez, Natalia de la Llama-Celis, Pilar Calmarza, Olivia Sierra-Gabarda, Elena Betoré-Glaria, María Martínez-de Lagos, Lucía Martínez-Barredo, María Espinosa-Pérez, Jose Miguel Arbones-Mainar
SARS-CoV-2 Infection Induces a Dual Response in Liver Function Tests: Association with Mortality during Hospitalization. Biomedicines 8 (9) (2020)